BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 26377837)

  • 1. Exome sequencing of lymphomas from three dog breeds reveals somatic mutation patterns reflecting genetic background.
    Elvers I; Turner-Maier J; Swofford R; Koltookian M; Johnson J; Stewart C; Zhang CZ; Schumacher SE; Beroukhim R; Rosenberg M; Thomas R; Mauceli E; Getz G; Palma FD; Modiano JF; Breen M; Lindblad-Toh K; Alföldi J
    Genome Res; 2015 Nov; 25(11):1634-45. PubMed ID: 26377837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prevalence and characterisation of TRAF3 and POT1 mutations in canine B-cell lymphoma.
    Smith PAD; Waugh EM; Crichton C; Jarrett RF; Morris JS
    Vet J; 2020 Dec; 266():105575. PubMed ID: 33323169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression profiling reveals transcriptional regulation by Fbxw7/mTOR pathway in radiation-induced mouse thymic lymphomas.
    Snijders AM; Liu Y; Su L; Huang Y; Mao JH
    Oncotarget; 2015 Dec; 6(42):44794-805. PubMed ID: 26575021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic inactivation of TRAF3 in canine and human B-cell lymphoma.
    Bushell KR; Kim Y; Chan FC; Ben-Neriah S; Jenks A; Alcaide M; Fornika D; Grande BM; Arthur S; Gascoyne RD; Steidl C; Morin RD
    Blood; 2015 Feb; 125(6):999-1005. PubMed ID: 25468570
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Sakthikumar S; Elvers I; Kim J; Arendt ML; Thomas R; Turner-Maier J; Swofford R; Johnson J; Schumacher SE; Alföldi J; Axelsson E; Couto CG; Kisseberth WC; Pettersson ME; Getz G; Meadows JRS; Modiano JF; Breen M; Kierczak M; Forsberg-Nilsson K; Marinescu VD; Lindblad-Toh K
    Cancer Res; 2018 Jul; 78(13):3421-3431. PubMed ID: 29724721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T-cell-derived malignant lymphoma in the boxer breed.
    Lurie DM; Lucroy MD; Griffey SM; Simonson E; Madewell BR
    Vet Comp Oncol; 2004 Sep; 2(3):171-5. PubMed ID: 19379305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breed-associated risks for developing canine lymphoma differ among countries: an European canine lymphoma network study.
    Comazzi S; Marelli S; Cozzi M; Rizzi R; Finotello R; Henriques J; Pastor J; Ponce F; Rohrer-Bley C; Rütgen BC; Teske E
    BMC Vet Res; 2018 Aug; 14(1):232. PubMed ID: 30081964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FBXW7 mutation in adult T-cell and B-cell acute lymphocytic leukemias.
    Song JH; Schnittke N; Zaat A; Walsh CS; Miller CW
    Leuk Res; 2008 Nov; 32(11):1751-5. PubMed ID: 18485478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BCL11B, FLT3, NOTCH1 and FBXW7 mutation status in T-cell acute lymphoblastic leukemia patients.
    Kraszewska MD; Dawidowska M; Kosmalska M; Sędek L; Grzeszczak W; Kowalczyk JR; Szczepański T; Witt M;
    Blood Cells Mol Dis; 2013 Jan; 50(1):33-8. PubMed ID: 23040356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic mutational profiling analysis of T cell acute lymphoblastic leukemia reveal mutant FBXW7 as a prognostic indicator for inferior survival.
    Yuan L; Lu L; Yang Y; Sun H; Chen X; Huang Y; Wang X; Zou L; Bao L
    Ann Hematol; 2015 Nov; 94(11):1817-28. PubMed ID: 26341754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BCL2 mutation spectrum in B-cell non-Hodgkin lymphomas and patterns associated with evolution of follicular lymphoma.
    Burkhard R; Bhagat G; Cogliatti SB; Rossi D; Gaidano G; Pasqualucci L; Novak U
    Hematol Oncol; 2015 Mar; 33(1):23-30. PubMed ID: 24496723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FBXW7 and NOTCH1 mutations in childhood T cell acute lymphoblastic leukaemia and T cell non-Hodgkin lymphoma.
    Park MJ; Taki T; Oda M; Watanabe T; Yumura-Yagi K; Kobayashi R; Suzuki N; Hara J; Horibe K; Hayashi Y
    Br J Haematol; 2009 Apr; 145(2):198-206. PubMed ID: 19245433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The genomic landscape of mantle cell lymphoma is related to the epigenetically determined chromatin state of normal B cells.
    Zhang J; Jima D; Moffitt AB; Liu Q; Czader M; Hsi ED; Fedoriw Y; Dunphy CH; Richards KL; Gill JI; Sun Z; Love C; Scotland P; Lock E; Levy S; Hsu DS; Dunson D; Dave SS
    Blood; 2014 May; 123(19):2988-96. PubMed ID: 24682267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Control of genomic instability and epithelial tumor development by the p53-Fbxw7/Cdc4 pathway.
    Perez-Losada J; Mao JH; Balmain A
    Cancer Res; 2005 Aug; 65(15):6488-92. PubMed ID: 16061623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical impact of NOTCH1 and/or FBXW7 mutations, FLASH deletion, and TCR status in pediatric T-cell lymphoblastic lymphoma.
    Callens C; Baleydier F; Lengline E; Ben Abdelali R; Petit A; Villarese P; Cieslak A; Minard-Colin V; Rullier A; Moreau A; Baruchel A; Schmitt C; Asnafi V; Bertrand Y; Macintyre E
    J Clin Oncol; 2012 Jun; 30(16):1966-73. PubMed ID: 22547598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic implications of mutations in NOTCH1 and FBXW7 in childhood T-ALL treated according to the NOPHO ALL-1992 and ALL-2000 protocols.
    Fogelstrand L; Staffas A; Wasslavik C; Sjögren H; Söderhäll S; Frost BM; Forestier E; Degerman S; Behrendtz M; Heldrup J; Karrman K; Johansson B; Heyman M; Abrahamsson J; Palmqvist L
    Pediatr Blood Cancer; 2014 Mar; 61(3):424-30. PubMed ID: 24424791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NOTCH1 and/or FBXW7 mutations predict for initial good prednisone response but not for improved outcome in pediatric T-cell acute lymphoblastic leukemia patients treated on DCOG or COALL protocols.
    Zuurbier L; Homminga I; Calvert V; te Winkel ML; Buijs-Gladdines JG; Kooi C; Smits WK; Sonneveld E; Veerman AJ; Kamps WA; Horstmann M; Petricoin EF; Pieters R; Meijerink JP
    Leukemia; 2010 Dec; 24(12):2014-22. PubMed ID: 20861909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exome sequencing of serous endometrial tumors identifies recurrent somatic mutations in chromatin-remodeling and ubiquitin ligase complex genes.
    Le Gallo M; O'Hara AJ; Rudd ML; Urick ME; Hansen NF; O'Neil NJ; Price JC; Zhang S; England BM; Godwin AK; Sgroi DC; ; Hieter P; Mullikin JC; Merino MJ; Bell DW
    Nat Genet; 2012 Dec; 44(12):1310-5. PubMed ID: 23104009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased frequency of CD45 negative T cells (T zone cells) in older Golden retriever dogs.
    Hughes KL; Labadie JD; Yoshimoto JA; Dossey JJ; Burnett RC; Avery AC
    Vet Comp Oncol; 2018 Mar; 16(1):E109-E116. PubMed ID: 28905476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genome wide exploration of the methylome in aggressive B-cell lymphoma in Golden Retrievers reveals a conserved hypermethylome.
    Chu S; Avery A; Yoshimoto J; Bryan JN
    Epigenetics; 2022 Dec; 17(13):2022-2038. PubMed ID: 35912844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.